Clinical Trials in Minneapolis

Showing 4801-4820 of 14,456 trials

ACTIMMUNE in Intermediate Osteopetrosis

NCT02666768

This study evaluates the effects of ACTIMMUNE (IFN-γ1b) in children and adults with intermediate osteoporosis. All participants will receive treatment with ACTIMMUNE for 12 months. The investigators hypothesize that ACTIMMUNE will be tolerated by participants for the full 12 months and result in decreased disease severity.

Osteopetrosis

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center5 participantsStarted Feb 2016

Torrance, California, United States • Minneapolis, Minnesota, United States

COMPLETEDNA< 1 mile

duoABLE for People With Stroke and Their Caregivers

NCT05964400

The goal of this intervention study is to test whether a behavioral program that involves people with stroke and their caregivers is acceptable, safe, and can promote physically active lifestyles using enjoyable activities. Participant duos (person with stroke and their caregiver) will be asked to complete assessments at 2 timepoints, wear an activity tracker, participate in 12 sessions with an occupational therapist, and complete an interview.

StrokeStroke IschemicStroke Hemorrhagic+1 more

University of Minnesota16 participantsStarted Sep 2023

Minneapolis, Minnesota, United States

COMPLETEDPhase 38.7 miles

A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies

NCT02594124

The primary objective is to evaluate long-term safety and tolerability of nusinersen (ISIS 396443) administered by intrathecal (IT) injection to participants with Spinal Muscular Atrophy (SMA) who previously participated in investigational studies of nusinersen. The secondary objective is to examine the long-term efficacy of nusinersen administered by IT injection to participants with SMA who previously participated in investigational studies of nusinersen.

Spinal Muscular Atrophy

Biogen292 participantsStarted Nov 2015

Los Angeles, California, United States • Palo Alto, California, United States • Aurora, Colorado, United States +44 more locations

ACTIMMUNE in Intermediate Osteopetrosis

duoABLE for People With Stroke and Their Caregivers

A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies

Find Trials by Condition in Minneapolis

An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Milademetan in Advanced/Metastatic Solid Tumors

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure

Investigation of Clot in Ischemic Stroke and Hematoma Evacuation

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Hypotension Prediction Index Study (HPI Study)

Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840

Assessment of Macrophage Activation syndromE in STill's Disease

Comparative Effectiveness of Direct Admission & Admission Through Emergency Departments for Children

Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Rapid MRI for Assessing Functional Abilities and Predicting TBI Outcomes

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)